日本語View as Markdown

Protective effect of hydrogen-rich saline on decompression sickness in rats.

水素富化生理食塩水によるラット減圧症に対する保護効果

animal study injection / infusion positive

Abstract

Oxidative stress is a key contributor to the pathophysiology of decompression sickness (DCS). This animal study examined whether hydrogen-rich saline (0.86 mmol/L) administered intraperitoneally (10 ml/kg) at multiple time points—24 h and 12 h before, immediately before compression, and immediately after rapid decompression—could reduce DCS-related injury in male Sprague-Dawley rats (300–310 g). The incidence of DCS fell significantly from 67.57% to 35.14% in the hydrogen-rich saline group. Markers of pulmonary injury, including total protein in bronchoalveolar lavage fluid, myeloperoxidase activity, malondialdehyde (MDA), and 8-hydroxydeoxyguanosine levels in lung tissue, were all substantially reduced. Spinal cord MDA levels also decreased markedly. Histopathological examination corroborated these biochemical findings, showing attenuated tissue damage. The results suggest that antioxidant properties of molecular hydrogen underlie these protective effects.

Mechanism

Molecular hydrogen is thought to act as a selective antioxidant, reducing oxidative stress markers such as MDA and 8-hydroxydeoxyguanosine in lung and spinal cord tissues, and suppressing myeloperoxidase-mediated inflammatory responses associated with decompression sickness.

Bibliographic

Authors
Ni XX, Cai ZY, Fan DF, Liu Y, Zhang RJ, Liu SJ, et al.
Journal
Aviat Space Environ Med
Year
2011
PMID
21702310
DOI
10.3357/asem.2964.2011

Tags

Delivery:点滴投与 Mechanism:抗酸化酵素 ヒドロキシルラジカル消去 炎症抑制 脂質過酸化 酸化ストレス 活性酸素種

Delivery context

Intravenous hydrogen-saline infusion is a clinic-only route and is not viable for everyday self-administration. For routine hydrogen intake, inhalation is the most practical route, but inhalation carries explosion risk and concentration matters (empirical LFL of 10%; high-concentration 66% / 100% devices are not recommended).

Safety notes

Intravenous hydrogen-saline infusion is a clinic-only route and is not viable for everyday self-administration. For routine hydrogen intake, inhalation is the most practical route, but inhalation carries explosion risk and concentration matters (empirical LFL of 10%; high-concentration 66% / 100% devices are not recommended).

See also:

Cite as: H2 Papers — PMID 21702310. https://h2-papers.org/en/papers/21702310
Source: PubMed PMID 21702310